{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT04393298: Phase 1/Phase 2 Interventional Completed Advanced Solid Tumors
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:pertuzumab zuvotolimod [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01268566: Phase 2 Interventional Completed Glioblastoma Multiforme
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01119456: Phase 1 Interventional Completed Cancer
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03921528: Phase 2 Interventional Completed Spinal Muscular Atrophy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03379259: Phase 1/Phase 2 Interventional Terminated Advanced Solid Tumors
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02254005: Phase 1 Interventional Completed Breast Neoplasms
(2002)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ebronucimab [INN]
Source URL:
Class:
PROTEIN
